Contributing Member of the Healthcare Councils
Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.
All News Analyses by this Author
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
-
November 15, 2009
Oxford BioMedica Announces Update on ProSavin® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results | www.pipelinereview.com
I am happy to learn of this exciting new drug for the treatment of Parkinson's disease. -
Lurasidone will be an important new option for the treatment of Schizophrenia
August 29, 2009
LURASIDONE DEMONSTRATED EFFICACY IN TREATING PATIENTS WITH SCHIZOPHRENIA IN PIVOTAL PHASE 3 STUDY | www.pipelinereview.com
After much disappointment over the current Atypical Antipsychotics , Lurasidone shows great promise for treatment refractory Schizophrenics. -
New Treatment Option for the Hearing Impaired
August 22, 2009
Oticon Medical Receives FDA Clearance To Market Innovative Bone Anchored Hearing System | www.medicalnewstoday.com
Oticon's new bone anchored hearing implant might offer unique advantages to the hearing impaired. -
Treatment of Social Anxiety Disorderved
August 6, 2009
NeuroSearch successfully advances NSD-721 for treatment of social anxiety disorder and receives EUR 5 million in equity financing under the alliance with GlaxoSmithKline | www.pipelinereview.com
NeuroSearch new drug NSD-721 will be of great benefit to patients with Social Anxiety Disorder. -
Is this the end of Bifeprunoxyndrome.
August 3, 2009
Lundbeck, Solvay discontinue all joint R&D activities for bifeprunox to treat schizophrenia | www.pharmabiz.com
Bifeprunox initially looked like it might be a blockbuster for Solvoy when it was first studied. -
Naproxen and Alzheimer'Alzheimer's/s
July 18, 2009
Naproxen May Help Prevent Alzheimer's | www.webmd.com
We have been searching for a new class of drugs that will show true promise for Alzheimer's Dementia. -
July 13, 2009
REMERON(R) Now Approved In Japan For The Treatment Of Depression In Adult Patients | www.medicalnewstoday.com
Remeron has a unique mechanism of action which sets it apart from most other antidepressant drugs such as the SSRI's, the SNRI's, the TCA's, and the MAO-Inhibitors. It can be of great benefit to patients who do not respond to these other drugs. -
Johnson & Johnson to Tap into huge Alzheimer's Market
July 9, 2009
Johnson & Johnson puts $1.5bn in Elan for Alzheimer's vaccine | www.eurobiotechnews.eu
J&J hopes to take into the huge marketplace for Alzheimer's treatments. -
Biotech will Provide the Next Big Breakthroughs
July 5, 2009
Biotechnology can be the next big driver for the pharma sector | www.dnaindia.com
The Biotech industry will provide the next big breakthrough drugs for big Pharma. -
June 30, 2009
UCB Brings Neupro(R) Back To All Patients In Europe | www.medicalnewstoday.com
The return of Neupro will help to benefit many Patients. -
We must find a new way to target Alzheimer's Dementia
June 23, 2009
Genentech Gets A Clue On Alzheimer's | www.forbes.com
The current drugs used to treat Alzheimer's offer only limited success. It is good that the Pharmaceutical companies are now looking at a whole new class of drugs that may actually reverse the illness. -
June 23, 2009
LabCorp to Acquire Monogram Biosciences for $107M | www.genomeweb.com
Lab Corp now seeks to diversify into other markets. -
June 2, 2009
Malaria vaccine could be available by 2011: report | www.hindu.com
The new Anti-Malarial vaccine could offer hope to millions of third world patients who die each year from mosquito born Malaria. -
Fampridine SR / A novel approach to MS
June 1, 2009
Acorda’s Fampridine-SR Gets Priority Review | phoenix.corporate-ir.net
Fampridine SR will add a new and novel approach to the treatment of MS patients. -
What information do Physician Data Bases really provide?
May 19, 2009
In patients' hunt for care, doctor database 'a place to start' | www.usatoday.com
Do these Physician Data Bases really provide useful information? -
April 13, 2009
Cephalon to apply for FDA approval for Nuvigil for jet lag | www.reuters.com
I feel that Cephalon will have a lot of success with Nuvigil. Provigil has been used OFF-Label for many years to treat Jet-Lag. -
April 2, 2009
Sanofi moves on Solvay's pharma division | www.ft.com
This is a smart move for Sanofi-Aventis since Solvay has many excellent products as well as several important pipeline products. -
March 31, 2009
Study: Cholesterol drug lowers blood clot risk | hosted.ap.org
The statin drugs continue to show that they have new ways to treat a host of new illnesses. They are amazing drugs and I believe that they will help to lower future healthcare costs by preventing future diseases. -
Why Do so Few Hospitals have EMR
March 30, 2009
U.S. Hospitals Slow to Adopt E-Records | online.wsj.com
A recent survey found that less than 7 % of US Hospitals have adopted EMR. Even with the new federal stimulus package of incentives the cost of EMR systems is very high. These systems require monthly maintenance fees and continuous staff to fix IT problems. The cost of a paper records system is zero. Another factor is the recent cases of computer hackers accessing patient's medical records including personal data such as social security numbers , date of birth, and addresses. This has already happened at several institutions that use EMR and those institutions may now get sued by angry patients. Many patients are concerned and do not want to see physicians with EMR systems because they are concerned that personal information may be shared with insurance companies such as chronic health conditions( Diabetes, HIV, Mental Illness). This information may be used in the future to deny Health and Life Insurance policies. -
September 11, 2008
National Trends in Psychotherapy by Office-Based Psychiatrists | archpsyc.ama-assn.org
Unfortunately, many insurance payors do not realize that allowing psychotherapy visits may save the money in the long run by reducing the need for much more costly Inpatient psychiatric treatment. I find that my patients who receive psychotherapy are much less likely to miss work and much less likely to be hospitalized. Sincerely, Gregg Friedman MD
Page : 11 to 20 of 20
- Subscribe to Updates
-
This author consults with leading institutions through GLG
Most Popular Healthcare News
-
Mobile Advertising Set To Soar ? Yes, But What Is The Engine For Growth
November 17, 2009
-
Roche Receives H1N1 FDA Emergency Use Authorization
November 16, 2009
-
From a physician point of view
November 16, 2009
-
Zetia Now Off Best Practices List for MI Prevention, But is Niaspan > Diet?
November 15, 2009
-
November 15, 2009
-
www.medscape.com
Rapid DNA Test to Detect Clostridium difficile Infection Approved by FDA Today
-
www.medicalnewstoday.com
Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology
-
www.pipelinereview.com
-
www.nytimes.com
-
www.docguide.com
FDA: Ongoing Omalizumab Study Shows Increased Number of Cardiovascular Events